학술논문

Safety and effectiveness of regorafenib (REG) in patients with metastatic colorectal cancer (mCRC) in routine clinical practice: An interim analysis (IA) from the prospective, observational CORRELATE study.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; FEB 1 2017, 35 4, 2p. Supplement: S
Subject
Language
English
ISSN
15277755